Does Medicare cover Saxenda in 2026?
Medicare is inconsistent on GLP-1 coverage for the weight-loss indication, and reliably covers GLP-1s prescribed for type 2 diabetes. Saxenda is not on their preferred formulary as of May 2026. Below is what to expect, what to ask, and your backup plan if denied. The CMS Medicare GLP-1 Bridge (July 1, 2026 through Dec 31, 2027) covers Wegovy, Foundayo, and Zepbound KwikPen at a flat $50/month for eligible enrollees in participating Part D plans. Outside the Bridge, federal law (Medicare Modernization Act of 2003) still excludes weight-loss-only drugs; diabetes-indicated drugs (Ozempic, Mounjaro) are covered with a qualifying diagnosis.
What you'll actually pay for Saxenda on Medicare
| Path | Monthly cost |
|---|---|
| Medicare insurance + savings card | N/A |
| Medicare insurance, no savings card | $25–$100 |
| Branded telehealth (Hims/Ro/LifeMD) | $399 |
| Cash retail (full WAC) | $1,349 |
Medicare prior authorization requirements
Based on Medicare (Part D)'s public formulary documents and PBM coverage policies for Saxenda (and similar weight-loss GLP-1s) as of May 2026:
- GLP-1 Bridge tier: participating Part D plan + BMI criteria (no heart-disease documentation)
- Outside the Bridge: statute excludes weight-loss-only coverage
Coverage policies change frequently. Confirm against your specific plan's Summary of Benefits or by calling the member services number on your insurance card.
If Medicare denies your Saxenda prior auth
Three real options, in rough order of effort vs cost:
- Appeal the denial. Most denials are overturnable with the right documentation (BMI, comorbidity diagnosis, prior weight-loss attempts). Step-by-step appeal playbook.
- Branded telehealth (Hims, Ro, LifeMD) at around $399/month. Includes prescriber visit; ships within days. Provider comparison.
Saxenda coverage on other major insurers
Other GLP-1s on Medicare
| Drug | Indication | Coverage | |
|---|---|---|---|
| Wegovy | Weight loss | $50/mo Bridge | Details → |
| Ozempic | Type 2 diabetes | Yes (T2D only) | Details → |
| Wegovy (oral 25mg) | Weight loss | $50/mo Bridge | Details → |
| Zepbound | Weight loss | $50/mo Bridge | Details → |
| Mounjaro | Type 2 diabetes | Yes (T2D only) | Details → |
| Foundayo (orforglipron) | Weight loss | $50/mo Bridge | Details → |
Frequently asked questions
How do I know if my specific Medicare plan covers Saxenda?
Coverage varies dramatically by employer plan within the same carrier. Call the member-services number on your Medicare insurance card and ask: "Is Saxenda covered on my formulary, what tier, and does it require prior authorization?" Get the answer in writing or via the member portal. Your plan's Summary of Benefits and Coverage (SBC) document also lists the formulary tier.
Can I use the Saxenda savings card with Medicare?
No. Medicare members are excluded from manufacturer savings cards by the federal anti-kickback statute, regardless of plan. Manufacturer direct self-pay programs (LillyDirect, NovoCare) remain open to government-insurance members because they are cash pricing, not copay assistance.
What if Medicare requires step therapy before approving Saxenda?
Step therapy means trying (and failing) an older or cheaper drug first. Common step drugs for GLP-1s are phentermine, topiramate, or older Saxenda. If your prescriber documents medical reasons you cannot tolerate the step drug (or have a contraindication), they can request a step-therapy exception. This is a separate request from the prior auth and often succeeds when properly documented. Full appeal playbook here.
Related guides
Stay ahead of every GLP-1 development
We'll email you when something actually matters: new FDA approvals (Foundayo, CagriSema, retatrutide), pricing drops at LillyDirect/NovoCare, telehealth deals, clinical trial results, FDA recalls, and insurance policy changes. ~1-2 emails/month. No filler.